Dr. Matthew Bromwich is a Surgeon at CHEO and an Associate Professor of Otolaryngology at the University of Ottawa. He is the physician lead for the CHEO innovation program 8-80. Dr. Bromwich is the inventor of several medical devices and holds 5 other medical patents. He aims to democratize access to medical care by delivering innovative and inexpensive solutions. In particular, he is the inventor of the SHOEBOX audiometer which is a globally available hearing testing platform that has reached nearly 2 million people. Dr. Bromwich has published >30 papers and four book chapters on Otolaryngology and has held more than 12.7 million dollars of grant, research and investment funds. In 2014 he won the national “TELUS Award for mHealth Innovation”. In 2016 he was nominated for the E&Y Entrepreneur of the Year award and he and his team won the 2016 Interface Health Challenge for their work on mobile hearing testing and won the David E Mitchel prize at the 2018 Manning Innovation Awards.
Other areas research area: Innovation
Validation of SHOEBOX QuickTest hearing loss screening tool in individuals with cognitive impairment
Implementing this iPad-based screening tool in memory clinics could not only aid in the timely diagnosis of hearing loss, but also assist physicians in providing a better assessment of cognitive impairment by ruling out hearing loss as a confounding variable.
Predictors of postoperative respiratory complications in children undergoing adenotonsillectomy
Prediction modeling concurrently evaluating comorbidities and polysomnography metrics identified cardiac disease, airway anomaly, and young age as independent predictors of PRAEs. These findings suggest that medical comorbidity and age are more important factors in predicting PRAEs than PSG metrics in a medically complex population.